Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$5.65 - $7.47 $1.41 Million - $1.87 Million
-250,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$5.61 - $12.01 $1.4 Million - $3 Million
250,000 New
250,000 $1.4 Million
Q1 2020

May 15, 2020

SELL
$6.94 - $14.22 $932,736 - $1.91 Million
-134,400 Closed
0 $0
Q4 2019

Jan 31, 2020

BUY
$7.99 - $37.6 $1.07 Million - $5.05 Million
134,400 New
134,400 $1.08 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.